Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection
Antoni Sicras Mainar, Sabahattin Kaymakoglu
(Turk J Gastroenterol 2019; 30: 43-45) DOI: 10.5152/tjg.2019.28